Yüklüyor......
IL-21 in cancer immunotherapy: At the right place at the right time
Interleukin-21 (IL-21) has been described as a potent stimulator of antitumor T-cell immunity, but also of autoimmune reactions and oncogenesis. Antigen presenting cells genetically modified to release IL-21 allow for the expansion of tumor-specific T cells exhibiting favorable effector and growth c...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Landes Bioscience
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3716748/ https://ncbi.nlm.nih.gov/pubmed/23894713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24522 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|